| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
184AA3: a xenograft model of ER+ breast adenocarcinoma
|
Hines, William C.
|
|
2015
|
155 |
1 |
p. 37-52
|
article
|
| 2 |
A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer
|
Jacobs, C.
|
|
2015
|
155 |
1 |
p. 77-84
|
article
|
| 3 |
A tailored approach to regional nodal irradiation
|
Avisar, Eli
|
|
2015
|
155 |
1 |
p. 1-2
|
article
|
| 4 |
Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients
|
Liang, Diana H.
|
|
2015
|
155 |
1 |
p. 139-149
|
article
|
| 5 |
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype
|
Schroth, Werner
|
|
2015
|
155 |
1 |
p. 85-97
|
article
|
| 6 |
Clinical utility of reverse phase protein array for molecular classification of breast cancer
|
Negm, Ola H.
|
|
2015
|
155 |
1 |
p. 25-35
|
article
|
| 7 |
Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial
|
Hanai, Akiko
|
|
2015
|
155 |
1 |
p. 99-107
|
article
|
| 8 |
Epigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer
|
Branham, M. T.
|
|
2015
|
155 |
1 |
p. 13-23
|
article
|
| 9 |
Factors associated with radiation therapy incompletion for patients with early-stage breast cancer
|
Freedman, Rachel A.
|
|
2015
|
155 |
1 |
p. 187-199
|
article
|
| 10 |
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial
|
Mastro, Lucia Del
|
|
2015
|
155 |
1 |
p. 117-126
|
article
|
| 11 |
Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer
|
Kolben, Thomas
|
|
2015
|
155 |
1 |
p. 109-115
|
article
|
| 12 |
Metastatic breast cancer patients: attitudes toward tissue donation for rapid autopsy
|
Achkar, Tala
|
|
2015
|
155 |
1 |
p. 159-164
|
article
|
| 13 |
Progestin and breast cancer risk: a systematic review
|
Samson, Marsha
|
|
2015
|
155 |
1 |
p. 3-12
|
article
|
| 14 |
Rates of BRCA1/2 mutation testing among young survivors of breast cancer
|
Kehl, Kenneth L.
|
|
2015
|
155 |
1 |
p. 165-173
|
article
|
| 15 |
Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel
|
Yablonski-Peretz, Tamar
|
|
2015
|
155 |
1 |
p. 133-138
|
article
|
| 16 |
Survivin contributes to DNA repair by homologous recombination in breast cancer cells
|
Véquaud, Eloïse
|
|
2015
|
155 |
1 |
p. 53-63
|
article
|
| 17 |
The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom
|
Schimdt, Nina
|
|
2015
|
155 |
1 |
p. 151-157
|
article
|
| 18 |
The relationship between local recurrence and death in early-stage breast cancer
|
Sopik, Victoria
|
|
2015
|
155 |
1 |
p. 175-185
|
article
|
| 19 |
The therapy with negative pressure as a valid device to treat chronic breast infections
|
Fogacci, Tommaso
|
|
2015
|
155 |
1 |
p. 201-202
|
article
|
| 20 |
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
|
Metzger-Filho, Otto
|
|
2015
|
155 |
1 |
p. 127-132
|
article
|
| 21 |
Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets
|
Nakagawa, Saki
|
|
2015
|
155 |
1 |
p. 65-75
|
article
|
Journal description